ATLANTA, Oct. 10, 2024 (GLOBE NEWSWIRE) -- Femasys, Inc., (Nasdaq: FEMY), a leading biomedical company focused on addressing significant unmet needs of women worldwide with a broad portfolio of ...
SAN ANTONIO, Texas, Oct. 16, 2025 (GLOBE NEWSWIRE) -- Femasys Inc. (NASDAQ: FEMY), a leading biomedical innovator making fertility and non-surgical permanent birth control more accessible and ...
MADRID & BASKING RIDGE, N.J., October 31, 2025--(BUSINESS WIRE)--IVI RMA, the world’s leading reproductive medicine group, announced that joint research with Juno Genetics that utilized data from the ...
Infertility has a new definition in the U.S. — one that could make a big difference to would-be parents who are single or LGBTQ+. Last week, the American Society for Reproductive Medicine (ASRM) ...
Two posters presented at the American Society for Reproductive Medicine (ASRM) 2023 Scientific Congress & Expo showed trends in funding and insurance coverage for individuals seeking fertility care.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results